0001493152-23-005468.txt : 20230217 0001493152-23-005468.hdr.sgml : 20230217 20230217164816 ACCESSION NUMBER: 0001493152-23-005468 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230107 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dexter Susan CENTRAL INDEX KEY: 0001806764 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35570 FILM NUMBER: 23643459 MAIL ADDRESS: STREET 1: C/O SONNET BIOTHERAPEUTICS HOLDINGS, INC STREET 2: 100 OVERLOOK CENTER CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sonnet BioTherapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001106838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522102141 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-375-2227 MAIL ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: Chanticleer Holdings, Inc. DATE OF NAME CHANGE: 20050510 FORMER COMPANY: FORMER CONFORMED NAME: TULVINE SYSTEMS INC DATE OF NAME CHANGE: 20000214 4 1 ownership.xml X0306 4 2023-01-07 0 0001106838 Sonnet BioTherapeutics Holdings, Inc. SONN 0001806764 Dexter Susan 100 OVERLOOK CENTER, SUITE 102 PRINCETON, NJ 08540 0 1 0 0 Chief Technical Officer Common Stock 2023-01-07 4 D 0 14627 D 9040 D Common Stock 2023-01-07 4 A 0 14627 A 23667 D On December 14, 2022, the Reporting Person was granted 14,627 restricted stock units to be settled in shares of common stock, par value $0.0001. On January 7, 2023, the 14,627 restricted stock units granted to the Reporting Person were rescinded and canceled. On the same day, the Reporting Person was granted a restricted stock award of 14,627 shares of common stock. The shares in connection with the restricted stock award become fully vested on January 1, 2024, provided the Reporting Person remains in continuous service through such date. A Form 4 that was filed by the Reporting Person on December 22, 2022, incorrectly included amounts in Column 5 of Table I that did not reflect a 14:1 reverse stock split of the Issuer's common stock, effective September 16, 2022. Includes unvested restricted stock units. /s/ John Harry Cross III, power of attorney 2023-02-17